TY  - JOUR
AU  - Ibáñez, R
AU  - Mareque, M
AU  - Granados, R
AU  - Andía, D
AU  - García-Rojo, M
AU  - Quílez, J C
AU  - Oyagüez, I
PY  - 2021
DO  - 10.1186/s12905-021-01310-8
UR  - http://hdl.handle.net/10668/17639
T2  - BMC women's health
AB  - HPV cervical cancer screening (CCS) must use validated HPV tests based on the molecular detection of either viral mRNA (Aptima HPV Assay-AHPV) or DNA. AHPV has demonstrated the same cross-sectional and longitudinal sensitivity for the detection of...
LA  - en
KW  - Aptima HPV assay
KW  - Cervical cancer screening
KW  - Cost analysis
KW  - Human papilloma virus
KW  - Colposcopy
KW  - Costs and Cost Analysis
KW  - Cross-Sectional Studies
KW  - DNA, Viral
KW  - Early Detection of Cancer
KW  - Female
KW  - Humans
KW  - Molecular Diagnostic Techniques
KW  - Papillomaviridae
KW  - Papillomavirus Infections
KW  - Pregnancy
KW  - Sensitivity and Specificity
KW  - Spain
KW  - Uterine Cervical Neoplasms
TI  - Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain.
TY  - research article
VL  - 21
ER  -